Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares HPV-positive (p16) head and neck cancer, Penile cancer, Fluorouracil (5-FU), PD-1 and the tag genitourinary.
Shares HPV-positive (p16) head and neck cancer, Oncogenic viruses, Vulvar cancer, Anal cancer (squamous cell carcinoma) and the tag rare.
Shares Cisplatin and the tag rare.
Shares Rare and paediatric cancers without markets, PD-1, IMRT / IGRT (modern external beam), Cisplatin and the tag rare.
Shares HPV-positive (p16) head and neck cancer, Penile cancer, Brachytherapy, Fluorouracil (5-FU) and the tag genitourinary.
Shares Rare and paediatric cancers without markets, IMRT / IGRT (modern external beam), Pembrolizumab, Cytotoxic chemotherapy and the tag rare.
Shares HPV-positive (p16) head and neck cancer, Chemoradiation (chemoradiotherapy, CRT), Brachytherapy, Cisplatin and the tag rare.
Shares PD-1, Cisplatin, Pembrolizumab, Cytotoxic chemotherapy and the tag rare.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.